Mansi Verma, Jaspreet Kaur, Mukesh Kumar, Kirti Kumari, Anjali Saxena, Shailly Anand, Aeshna Nigam, Vydianathan Ravi, Saurabh Raghuvanshi, Paramjit Khurana, Akhilesh K Tyagi, Jitendra P Khurana, Rup Lal
Index: J. Bacteriol. 193(19) , 5562-3, (2011)
Full Text: HTML
Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of A. mediterranei S699, with 9,575 predicted coding sequences.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
rifamycin B
CAS:13929-35-6 |
C39H49NO14 |
|
Evidence for a multidrug resistance-associated protein 1 (MR...
1999-01-01 [Life Sci. 64(9) , 763-74, (1999)] |
|
Phase shifts in the stoichiometry of rifamycin B fermentatio...
2006-12-15 [J. Biotechnol. 127(1) , 115-28, (2006)] |
|
Stereochemical assignment of intermediates in the rifamycin ...
2005-08-17 [J. Am. Chem. Soc. 127(32) , 11202-3, (2005)] |
|
Overproduction of rifamycin B by Amycolatopsis mediterranei ...
1998-01-01 [J. Antibiot. 51(1) , 58-63, (1998)] |
|
Expression of the bacterial hemoglobin gene from Vitreoscill...
2008-11-01 [J. Biosci. Bioeng. 106(5) , 493-7, (2008)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
